Skip to main content
. 2017 Jan 25;12(1):e0170741. doi: 10.1371/journal.pone.0170741

Fig 4. Box plots of levels of proteins selected for the validation experiment.

Fig 4

Levels of these selected biomarkers were determined in serum of healthy controls (n = 20), sarcoidosis (n = 20), hypersensitivity pneumonitis (HP) (n = 20), and IPF patients (n = 20) using ELISA, n, number of subjects. P-values were calculated with one-way ANOVA test. *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001 compared to IPF group.